Skip to content

Funding and partnership opportunities: MEDICA, accelerators, G-BA and international programmes

Current opportunity set

MedicalCooling and EthicalSaving are tracking several time-sensitive programmes that could accelerate AIRCHILL development, validation and market access.

High-priority opportunities

  • MEDICA Healthcare Innovation World Cup / MEDICA START-UP COMPETITION: international visibility, investors and strategic-industry contacts for medical-device startups.
  • CO-AX / Sahlgrenska Science Park: MedTech and life-science acceleration with clinical, regulatory, reimbursement and investor access.
  • Osnabrück Healthcare Accelerator (OHA): German MedTech programme with support around certification, reimbursement and business development.
  • KMU-innovativ Medizintechnik: potential German R&D funding for technical and preclinical development.
  • EIC Accelerator: major European scale-up instrument for sufficiently mature innovation projects.
  • Innowwide / Eurostars: international market-feasibility and cross-border R&D routes where eligibility and project maturity fit.
  • G-BA Innovationsfonds: potentially relevant for care-pathway, implementation and health-economic research rather than pure device development.

Clinical and industry networking

Relevant 2026 routes also include ERC Resuscitation, Charité acute/emergency medicine networks, MEDICA, EMS research fellowships and OEM ecosystems around ventilation, monitoring, defibrillation, telemedicine and airway systems.

Why this matters

The optimal AIRCHILL financing stack is unlikely to come from a single source. A staged combination of grant funding, clinical collaborations, accelerators, strategic OEM relationships and later venture or EIC capital can reduce dilution while building the evidence required for regulatory and commercial milestones.

Next-action principle

Each programme should be screened against:

  • applicant eligibility,
  • TRL and clinical maturity,
  • funding versus equity terms,
  • permitted clinical work,
  • geographic restrictions,
  • access to hospitals or EMS partners,
  • regulatory support,
  • deadline and preparation burden.

This page records strategic opportunities; it does not imply acceptance into, endorsement by or funding from any listed programme.